164 related articles for article (PubMed ID: 29518696)
1. EAF2 and p53 Co-Regulate STAT3 Activation in Prostate Cancer.
Pascal LE; Wang Y; Zhong M; Wang D; Chakka AB; Yang Z; Li F; Song Q; Rigatti LH; Chaparala S; Chandran U; Parwani AV; Wang Z
Neoplasia; 2018 Apr; 20(4):351-363. PubMed ID: 29518696
[TBL] [Abstract][Full Text] [Related]
2. Combined Loss of EAF2 and p53 Induces Prostate Carcinogenesis in Male Mice.
Wang Y; Pascal LE; Zhong M; Ai J; Wang D; Jing Y; Pilch J; Song Q; Rigatti LH; Graham LE; Nelson JB; Parwani AV; Wang Z
Endocrinology; 2017 Dec; 158(12):4189-4205. PubMed ID: 29029019
[TBL] [Abstract][Full Text] [Related]
3. Concomitant loss of EAF2/U19 and Pten synergistically promotes prostate carcinogenesis in the mouse model.
Ai J; Pascal LE; O'Malley KJ; Dar JA; Isharwal S; Qiao Z; Ren B; Rigatti LH; Dhir R; Xiao W; Nelson JB; Wang Z
Oncogene; 2014 May; 33(18):2286-94. PubMed ID: 23708662
[TBL] [Abstract][Full Text] [Related]
4. FOXA1 modulates EAF2 regulation of AR transcriptional activity, cell proliferation, and migration in prostate cancer cells.
Guo W; Keener AL; Jing Y; Cai L; Ai J; Zhang J; Fisher AL; Fu G; Wang Z
Prostate; 2015 Jun; 75(9):976-87. PubMed ID: 25808853
[TBL] [Abstract][Full Text] [Related]
5. Conditional Deletion of Eaf1 Induces Murine Prostatic Intraepithelial Neoplasia in Mice.
Pascal LE; Su F; Wang D; Ai J; Song Q; Wang Y; O'Malley KJ; Cross B; Rigatti LH; Green A; Dhir R; Wang Z
Neoplasia; 2019 Aug; 21(8):752-764. PubMed ID: 31229879
[TBL] [Abstract][Full Text] [Related]
6. EAF2 regulates DNA repair through Ku70/Ku80 in the prostate.
Ai J; Pascal LE; Wei L; Zang Y; Zhou Y; Yu X; Gong Y; Nakajima S; Nelson JB; Levine AS; Lan L; Wang Z
Oncogene; 2017 Apr; 36(15):2054-2065. PubMed ID: 27721405
[TBL] [Abstract][Full Text] [Related]
7. Tumor suppressor U19/EAF2 regulates thrombospondin-1 expression via p53.
Su F; Pascal LE; Xiao W; Wang Z
Oncogene; 2010 Jan; 29(3):421-31. PubMed ID: 19826414
[TBL] [Abstract][Full Text] [Related]
8. Regulation of ELL2 stability and polyubiquitination by EAF2 in prostate cancer cells.
Yang T; Jing Y; Dong J; Yu X; Zhong M; Pascal LE; Wang D; Zhang Z; Qiao B; Wang Z
Prostate; 2018 Nov; 78(15):1201-1212. PubMed ID: 30009504
[TBL] [Abstract][Full Text] [Related]
9. U19/Eaf2 knockout causes lung adenocarcinoma, B-cell lymphoma, hepatocellular carcinoma and prostatic intraepithelial neoplasia.
Xiao W; Zhang Q; Habermacher G; Yang X; Zhang AY; Cai X; Hahn J; Liu J; Pins M; Doglio L; Dhir R; Gingrich J; Wang Z
Oncogene; 2008 Mar; 27(11):1536-44. PubMed ID: 17873910
[TBL] [Abstract][Full Text] [Related]
10. Expression and prognostic significance of ELL-associated factor 2 in human prostate cancer.
Zang Y; Dong Y; Yang D; Xue B; Li F; Gu P; Zhao H; Wang S; Zhou S; Ying R; Wang Z; Shan Y
Int Urol Nephrol; 2016 May; 48(5):695-700. PubMed ID: 26895851
[TBL] [Abstract][Full Text] [Related]
11. Concurrent EAF2 and ELL2 loss phenocopies individual EAF2 or ELL2 loss in prostate cancer cells and murine prostate.
Zhong M; Pascal LE; Cheng E; Masoodi KZ; Chen W; Green A; Cross BW; Parrinello E; Rigatti LH; Wang Z
Am J Clin Exp Urol; 2018; 6(6):234-244. PubMed ID: 30697579
[TBL] [Abstract][Full Text] [Related]
12. Pirin down-regulates the EAF2/U19 protein and alleviates its growth inhibition in prostate cancer cells.
Qiao Z; Wang D; Hahn J; Ai J; Wang Z
Prostate; 2014 Feb; 74(2):113-20. PubMed ID: 24272884
[TBL] [Abstract][Full Text] [Related]
13. Identification of a genetic interaction between the tumor suppressor EAF2 and the retinoblastoma protein (Rb) signaling pathway in C. elegans and prostate cancer cells.
Cai L; Wang D; Fisher AL; Wang Z
Biochem Biophys Res Commun; 2014 May; 447(2):292-8. PubMed ID: 24727455
[TBL] [Abstract][Full Text] [Related]
14. Conditional deletion of ELL2 induces murine prostate intraepithelial neoplasia.
Pascal LE; Masoodi KZ; Liu J; Qiu X; Song Q; Wang Y; Zang Y; Yang T; Wang Y; Rigatti LH; Chandran U; Colli LM; Vencio RZN; Lu Y; Zhang J; Wang Z
J Endocrinol; 2017 Nov; 235(2):123-136. PubMed ID: 28870994
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis induction and growth suppression by U19/Eaf2 is mediated through its ELL-binding domain.
Hahn J; Xiao W; Jiang F; Simone F; Thirman MJ; Wang Z
Prostate; 2007 Feb; 67(2):146-53. PubMed ID: 17044034
[TBL] [Abstract][Full Text] [Related]
16. Regulation of tumor suppressor EAF2 polyubiquitination by ELL1 and SIAH2 in prostate cancer cells.
Yu X; Ai J; Cai L; Jing Y; Wang D; Dong J; Pascal LE; Zhang J; Luo R; Wang Z
Oncotarget; 2016 May; 7(20):29245-54. PubMed ID: 27058417
[TBL] [Abstract][Full Text] [Related]
17. JMJD2A attenuation affects cell cycle and tumourigenic inflammatory gene regulation in lipopolysaccharide stimulated neuroectodermal stem cells.
Das A; Chai JC; Jung KH; Das ND; Kang SC; Lee YS; Seo H; Chai YG
Exp Cell Res; 2014 Nov; 328(2):361-78. PubMed ID: 25193078
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA alteration and putative target genes in high-grade prostatic intraepithelial neoplasia and prostate cancer: STAT3 and ZEB1 are upregulated during prostate carcinogenesis.
Cha YJ; Lee JH; Han HH; Kim BG; Kang S; Choi YD; Cho NH
Prostate; 2016 Jul; 76(10):937-47. PubMed ID: 27017949
[TBL] [Abstract][Full Text] [Related]
19. Mutant p53 (G199V) gains antiapoptotic function through signal transducer and activator of transcription 3 in anaplastic thyroid cancer cells.
Kim TH; Lee SY; Rho JH; Jeong NY; Soung YH; Jo WS; Kang DY; Kim SH; Yoo YH
Mol Cancer Res; 2009 Oct; 7(10):1645-54. PubMed ID: 19825993
[TBL] [Abstract][Full Text] [Related]
20. IL-6/STAT3/ARF: the guardians of senescence, cancer progression and metastasis in prostate cancer.
Pencik J; Wiebringhaus R; Susani M; Culig Z; Kenner L
Swiss Med Wkly; 2015; 145():w14215. PubMed ID: 26691865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
